{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:20:45Z","timestamp":1773156045463,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"29-30","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.04.056","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T02:22:49Z","timestamp":1304821369000},"page":"4848-4852","source":"Crossref","is-referenced-by-count":16,"title":["Improved formulation and lyophilization cycle for rBCG vaccine"],"prefix":"10.1016","volume":"29","author":[{"given":"Tom H.","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianli","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (29)","key":"10.1016\/j.vaccine.2011.04.056_bib0005","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/j.vaccine.2005.03.001","article-title":"New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development","volume":"23","author":"Kamath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.04.056_bib0010","unstructured":"World Health Organization (WHO). Global tuberculosis control\u2014epidemiology, strategy, financing. WHO\/HTM\/TB\/2009.411."},{"key":"10.1016\/j.vaccine.2011.04.056_bib0015","unstructured":"WHO. WHO vaccine preventable diseases: monitoring system\u20142000 global summary. WHO\/V&B\/00.32."},{"issue":"November (6)","key":"10.1016\/j.vaccine.2011.04.056_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7883\/yoken.JJID.2007.331","article-title":"Historical review of BCG vaccine in Japan","volume":"60","author":"Yamamoto","year":"2007","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.04.056_bib0025","first-page":"113","article-title":"Reasons for instability of bacterial vaccines","volume":"87","author":"Corbel","year":"1996","journal-title":"Dev Biol Stand"},{"issue":"July (33)","key":"10.1016\/j.vaccine.2011.04.056_bib0030","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.04.056_bib0035","doi-asserted-by":"crossref","unstructured":"WHO. Requirements for biological substances. 1988;11:60\u201392.","DOI":"10.1016\/0140-1750(88)90027-9"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.056_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0092-1157(88)90025-X","article-title":"The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine","volume":"16","author":"Gheorghiu","year":"1988","journal-title":"J Biol Stand"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2011.04.056_bib0045","first-page":"125","article-title":"Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains","volume":"134","author":"Gheorghiu","year":"1983","journal-title":"Ann Immunol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.04.056_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.femsle.2004.11.043","article-title":"The effect of passaging in liquid media and storage on Mycobacterium bovis\u2014BCG growth capacity and infectivity","volume":"243","author":"Nascimento","year":"2005","journal-title":"FEMS Microbiol Lett"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2011.04.056_bib0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1208\/s12249-010-9391-2","article-title":"Naked plasmid DNA formulation: effect of different disaccharides on stability after lyophilisation","volume":"11","author":"Quaak","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.04.056_bib0060","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11095-004-1887-6","article-title":"Comparative investigation by two analytical approaches of enthalpy relaxation for glassy glucose, sucrose, maltose and trehalose","volume":"22","author":"Kawai","year":"2005","journal-title":"Pharm Res"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.04.056_bib0065","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1023\/B:PHAM.0000033003.17251.c3","article-title":"Effect of preparation method on physical properties of amorphous trehalose","volume":"21","author":"Surana","year":"2004","journal-title":"Pharm Res"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.04.056_bib0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cryobiol.2008.01.003","article-title":"Evaluation of trehalose and sucrose as cryoprotectants for hemtopoietic stem cells of umbilical cord blood","volume":"56","author":"Rodrigues","year":"2008","journal-title":"Cryobiology"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.04.056_bib0075","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s11095-007-9296-2","article-title":"Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose","volume":"24","author":"Yoshioka","year":"2007","journal-title":"Pharm Res"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.04.056_bib0080","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1023\/A:1013054431517","article-title":"Effect of Moisture on the Stability of a lyophilized humanized monoclonal antibody formulation","volume":"18","author":"Breen","year":"2001","journal-title":"Pharm Res"},{"issue":"March (1\u20133)","key":"10.1016\/j.vaccine.2011.04.056_bib0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0169-409X(00)00144-7","article-title":"Factors affecting short-term and long-term stabilities of proteins","volume":"46","author":"Arakawa","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.04.056_bib0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0011-2240(89)90047-3","article-title":"Effect of trehalose on the phase properties of hydrated and lyophilized dipalmitoylphosphatidylcholine multilayers","volume":"26","author":"Tsvetkov","year":"1989","journal-title":"Cryobiology"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.04.056_bib0095","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1021\/js980069t","article-title":"Effect of excipients of the stability and structure of lyophilized recombinant human growth hormone","volume":"87","author":"Costantino","year":"1998","journal-title":"J Pharm Sci"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2011.04.056_bib0100","first-page":"94","article-title":"Physicochemical characterization of the freezing behavior of mannitol\u2013human serum albumin formulations","volume":"7","author":"Hawe","year":"2006","journal-title":"AAPS PharmSciTech"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.04.056_bib0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/js980001d","article-title":"The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute","volume":"87","author":"Kim","year":"1998","journal-title":"J Pharm Sci"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.04.056_bib0110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11095-006-9158-3","article-title":"Influence of processing conditions on the physical state of mannitol\u2014implications in freeze-drying","volume":"24","author":"Liao","year":"2007","journal-title":"Pharm Res"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.04.056_bib0115","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1007\/s11095-005-7625-x","article-title":"Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol\u2014implications in freeze-drying","volume":"22","author":"Liao","year":"2005","journal-title":"Pharm Res"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.04.056_bib0120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1023\/A:1016129521485","article-title":"Crystallization of mannitol below Tg\u2032 during freeze-drying in binary and ternary aqueous systems","volume":"19","author":"Pyne","year":"2002","journal-title":"Pharm Res"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.04.056_bib0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/js980323h","article-title":"Existence of a mannitol hydrate during freeze-drying and practical implications","volume":"88","author":"Yu","year":"1999","journal-title":"J Pharm Sci"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.04.056_bib0130","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/jps.10094","article-title":"Mannitol\u2013sucrose mixtures\u2014versatile formulations for protein lyophilization","volume":"91","author":"Johnson","year":"2002","journal-title":"J Pharm Sci"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.04.056_bib0135","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1023\/A:1016177404647","article-title":"Crystallization behavior of mannitol in frozen aqueous solutions","volume":"19","author":"Cavatur","year":"2002","journal-title":"Pharm Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T15:55:19Z","timestamp":1712418919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11006013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":27,"journal-issue":{"issue":"29-30","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11006013"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}